patent/TW-201805287-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201805287-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-527 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
filingDate	2017-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db25eaec2b018021208e3d834d76fa52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ffda8530530077b544f04daa05cf821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c91a989c57cc6c9818a6662cd26baf5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f7920b13c87bcdc8242fc19bdf4358b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77b9fa7336517d5916393661f1e6b3e8
publicationDate	2018-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	TW-201805287-A
titleOfInvention	Acetylene derivative
abstract	The present invention relates to compounds of formula IA and IB Or a pharmaceutically acceptable salt or acid addition salt thereof, a racemic mixture, or its corresponding enantiomer and / or optical isomer and / or stereoisomer. These compounds can be used to treat Parkinson's disease, anxiety, vomiting, obsessive-compulsive disorder, autism, neuroprotection, cancer, depression and type 2 diabetes.
priorityDate	2016-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134201564 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430639138

Total number of triples: 32.